Director's dealings

RNS Number : 5373U
Futura Medical PLC
18 January 2017
 

 For immediate release

18 January 2017

 

 

 

 

Futura Medical plc

("Futura" or the "Company")

 

Director's dealings

 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has today received notification that James Barder, the Chief Executive of the Company, has gifted in aggregate 50,000 ordinary shares in the Company to a shareholding account jointly held by his children.

 

Following the transfer, Mr. Barder's revised aggregate beneficial and non-beneficial holding is 1,478,830 ordinary shares, representing 1.23 per cent. of the Company's issued share capital.

 

Further details are contained within the notification below, made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

 

For further information:

 

Futura Medical plc

 

+ 44 (0) 1483 685 670

James Barder, Chief Executive


Mail to: James.Barder@futuramedical.com

www.futuramedical.com

 

N+1 Singer

 

+44 (0) 20 7496 3000

Aubrey Powell / Liz Yong

Brough Ransom - Sales


 

Buchanan

 

+ 44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson


 

Notes to editors:

 

About Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange (AIM: FUM).

 

www.futuramedical.com

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

James Barder

2

 

Reason for the notification

 

a)

 

Position/status

 

Director/ PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Futura Medical plc

b)

 

LEI

 

21380053QLT46UNV2303

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2p each

 

GB0033278473

b)

 

Nature of the transaction

 

 

Transfer of shares to joint account of adult children (not PCAs)

c)

 

Prices and volumes

 

 

 

Price(s)

 

Volume(s)

0 pence

50,000

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

Not applicable

 

 

e)

 

Date of the transaction

 

17 January 2017

f)

 

Place of the transaction

 

Outside a trading venue

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZMGMMVRKGNZM
UK 100

Latest directors dealings